dc.creatorMiller, Jonathan
dc.creatorCantor, Amanda
dc.creatorZachariah, Philip
dc.creatorAhn, Danielle
dc.creatorMartinez, Mercedes
dc.creatorMargolis, Kara
dc.date.accessioned2020-07-28T16:47:30Z
dc.date.accessioned2022-09-23T18:10:24Z
dc.date.available2020-07-28T16:47:30Z
dc.date.available2022-09-23T18:10:24Z
dc.date.created2020-07-28T16:47:30Z
dc.identifierhttps://doi.org/10.1053/j.gastro.2020.05.079
dc.identifierhttp://hdl.handle.net/20.500.12010/11282
dc.identifierhttps://doi.org/10.1053/j.gastro.2020.05.079
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3496775
dc.description.abstractUntil recently, the clinical course of coronavirus disease 2019 (COVID-19) in children has been reported to be largely mild.1,2 Recently, it has become evident that a subset of children exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can become critically ill with a condition now referred to as multisystem inflammatory syndrome in children (MIS-C), characterized by systemic hyperinflammation with fever and multi-system organ dysfunction.3 Gastrointestinal symptoms are increasingly recognized to be associated with the presentation of MIS-C, potentially confusing the diagnosis of MIS-C with other common, less toxic gastrointestinal infections and even inflammatory bowel disease. In the first published correspondence describing MIS-C in eight patients from the United Kingdom, 100% presented with GI symptoms.4 Similarly 6 of 10 patients from an Italian cohort had GI issues.5 This is In contrast to adults, who most commonly present with respiratory symptoms, and report GI symptoms in <10-15% of cases.6,7 We examined whether similar presentations and prevalence extended to our comparatively larger U.S. cohort of 44 patients (<21 years old) with MIS-C.
dc.publisherGastroenterology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectGastrointestinal symptoms
dc.subjectNovel multisystem inflammatory
dc.subjectSyndrome in children (MIS-C)
dc.subjectCOVID-19
dc.titleGastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases


Este ítem pertenece a la siguiente institución